Scarpa Fascia Preservation to Reduce Seroma Rate on Massive Weight Loss Patients Undergoing Abdominoplasty: A Comparative Study
Journal of Clinical Medicine · 13.01.2023 · 12 (2) · 636
DOI: 10.3390/jcm12020636 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 13.01.2023. Verfasst von Oskari Repo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic and General Surgery, Turku University Hospital, University of Turku, 20500 Turku, Finland. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
(1)
Background
An increasing number of patients undergo bariatric surgery and seek body contouring surgery after massive weight loss (MWL). Abdominoplasty itself is associated with a high complication rate in these patients, particularly due to seroma formation. Scarpa fascia preservation (SFP) has been proven to be an efficient method of reducing seroma rates. We aimed to evaluate the possible benefits of SFP on massive weight loss patients comparatively. (2)
Methods
This is a single-center retrospective comparative study encompassing 202 MWL patients operated between 2009 and 2019 at Turku University Hospital. Patients included in the study had a preoperative weight loss greater than 30 kg. Of them, 149 went through traditional abdominoplasty and 53 abdominoplasties with SFP. The primary outcome measure was seroma occurrence, while secondary outcomes included drainage amount, hospital stay, surgical site occurrence, and need for blood transfusion. (3)
Results
The only statistically significant difference between groups on patients’ demographics was the sex ratio, favoring females in the control group (43:10, 81% vs. 130:19, 87%, p = 0.018). SFP significantly reduced seroma occurrence (9.4% vs. 26.2%, p = 0.011) and decreased mean drainage duration (3.7 ± 2.4 vs. 5.3 ± 3.2 days, p = 0.025). There was a trend towards lower drainage output (214.1 ± 162.2 mL vs. 341.9 ± 480.5 mL, p = 0.060) and fewer postoperative days on ward in the SFP group. Other complication incidences did not differ between the groups. The multivariable analysis did not show any significant factor for seroma formation or surgical site occurrence. (4)
Conclusions
Preserving Scarpa fascia on MWL patients may result in decreased seroma occurrence and a shorter time to drain removal.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Plastic and General Surgery, Turku University Hospital, University of Turku, 20500 Turku, Finland.
- Department of Plastic, Reconstructive, and Aesthetic Surgery, Geneva University Hospitals, Geneva University, 1205 Geneva, Switzerland.
- Department of Plastic, Reconstructive and Hand Surgery, University Hospital of Lausanne (CHUV), 1011 Lausanne, Switzerland.
- Perioperative Services, Intensive Care and Pain Medicine, Turku University Hospital, 20500 Turku, Finland.
- Department of Urology, Turku University Hospital, University of Turku, 20500 Turku, Finland.
ORCID-Profile: Oskari Repo, Carlo M Oranges, Panu Uusalo, Salvatore Giordano
Zitieren
APA
Repo, O., Oranges, C. M., di Summa, P. G., Uusalo, P., Anttinen, M., & Giordano, S. (2023). Scarpa Fascia Preservation to Reduce Seroma Rate on Massive Weight Loss Patients Undergoing Abdominoplasty: A Comparative Study. Journal of Clinical Medicine, 12(2), 636. https://doi.org/10.3390/jcm12020636
Vancouver
Repo O, Oranges CM, di Summa PG, Uusalo P, Anttinen M, Giordano S. Scarpa Fascia Preservation to Reduce Seroma Rate on Massive Weight Loss Patients Undergoing Abdominoplasty: A Comparative Study. Journal of Clinical Medicine. 2023;12(2):636. doi:10.3390/jcm12020636
BibTeX
@article{Repo2023,
author = {Repo, Oskari and Oranges, Carlo M and di Summa, Pietro G and Uusalo, Panu and Anttinen, Mikael and Giordano, Salvatore},
title = {Scarpa Fascia Preservation to Reduce Seroma Rate on Massive Weight Loss Patients Undergoing Abdominoplasty: A Comparative Study},
journal = {Journal of Clinical Medicine},
year = {2023},
volume = {12},
number = {2},
pages = {636},
doi = {10.3390/jcm12020636}
}
EUVIMED